Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7
Felicity C. Kalinowski(Harry Perkins Institute of Medical Research), Peter J. Leedman(University of Western Australia)
Cited by 86
Related Papers
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
|Molecular Cancer Therapeutics|2013|151